Benitec Biopharma Inc.

NASDAQ: BNTC · Real-Time Price · USD
12.93
0.27 (2.13%)
At close: Aug 15, 2025, 3:59 PM
11.05
-14.54%
After-hours: Aug 15, 2025, 07:55 PM EDT

Benitec Biopharma Income Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Revenue
n/a n/a n/a n/a 6K n/a n/a 7K 54K 14K 472K n/a 48K 25K n/a 2K 1K 1K 55K
Cost of Revenue
n/a n/a n/a 91K 90K 1K -106K 84K n/a 41K 102K 9K n/a n/a 102K 1K 7K 24.64K 134K
Gross Profit
n/a n/a n/a -91K -84K -1K 106K -77K 54K -27K 370K -9K 48K 25K -102K 1K -6K -23.64K -79K
Operating Income
-10.19M -8.61M -5.79M -5.55M -4.14M -6.93M -5.87M -4.55M -4.34M -5.61M -4.58M -4.74M -3.46M -4.83M -4.82M -3.85M -3.79M -3.26M -2.69M
Interest Income
n/a 823K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-9.35M -7.36M -5.06M -4.72M -4.28M -6.8M -5.95M -4.66M -4.4M -5.41M -5.09M -5.07M -3.27M -4.82M -5.04M -4M -3.91M -3.25M -2.72M
Net Income
-9.35M -7.36M -5.06M -4.72M -4.28M -6.8M -5.95M -4.66M -4.4M -5.21M -5.61M -5.07M -3.09M -4.82M -5.04M -4M -3.91M -3.25M -2.72M
Selling & General & Admin
4.21M 3.54M 2.21M 2.04M 1.49M 1.82M 1.55M 1.37M 1.23M 1.86M 1.92M 1.55M 1.34M 1.71M 2.04M 1.54M 1.03M 2.11M 1.84M
Research & Development
5.98M 5.07M 3.58M 3.51M 2.57M 5.1M 4.43M 3.19M 3.17M 3.76M 2.66M 3.18M 2.17M 3.15M 2.78M 2.32M 2.76M 1.17M 774K
Other Expenses
n/a n/a n/a n/a -16K -16K -18K -80K n/a 50K n/a n/a -29K n/a n/a n/a 7K 10K n/a
Operating Expenses
10.19M 8.61M 5.79M 5.46M 4.05M 6.93M 5.98M 4.56M 4.39M 5.62M 4.58M 4.73M 3.51M 4.86M 4.82M 3.86M 3.79M 3.28M 2.61M
Interest Expense
823K n/a n/a n/a 4K 6K 6K 8K 7K 9K 9K 10K 10K 11K 1K n/a 2K 2K n/a
Selling & Marketing Expenses
n/a n/a n/a 77K -90K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
n/a 8.61M 5.79M 5.55M 4.14M 6.93M 5.98M 4.56M 4.39M 5.62M 4.58M 4.74M 3.51M 4.86M 4.82M 3.86M 3.79M 3.26M 2.75M
Income Tax Expense
n/a n/a n/a n/a n/a -10K n/a n/a n/a -199K 513K -40K -185K 11K n/a n/a n/a 3K n/a
Shares Outstanding (Basic)
38.6M 22.08M 10.64M 10.09M 10.44M 10.3M 8.63M 6.58M 1.65M 6.48M 2.55M 1.92M 1.92M 1.92M 1.92M 1.66M 1.12M 1.01M 260.79K
Shares Outstanding (Diluted)
38.6M 22.08M 10.64M 10.09M 10.47M 10.31M 8.63M 6.58M 1.65M 6.49M 2.55M 1.92M 1.92M 1.92M 1.92M 1.66M 1.12M 1.01M 260.79K
EPS (Basic)
-0.24 -0.33 -0.48 -0.58 -0.82 -1.32 -1.38 -1.42 -2.67 -1.61 -4.39 -5.27 -3.21 -5.01 -5.25 -4.82 -7 -6.43 -20.84
EPS (Diluted)
-0.24 -0.33 -0.48 -0.58 -0.82 -1.32 -1.38 -1.42 -2.67 -1.6 -4.39 -5.27 -3.21 -5.01 -5.25 -4.82 -7 -6.43 -20.84
EBITDA
-10.19M -8.53M -5.7M -5.52M -4.18M -6.71M -5.87M -4.57M -4.3M -5.36M -4.98M -5M -3.15M -4.71M -4.94M -3.8M -3.79M -3.19M -2.6M
EBIT
n/a -8.61M -5.06M -5.47M -4.28M -6.79M -5.95M -4.65M -4.39M -5.4M -5.08M -5.06M -3.27M -4.82M -5.04M -3.85M -3.91M -3.25M -2.69M
Depreciation & Amortization
n/a 81K 91K 91K 90K 80K 82K 84K 93K 41K 102K 63K 114K 113K 102K 102K 115K 115K 92K